TTP plc

TTP’s radio frequency front end (RFFE) meets stringent low SWaP (Size, Weight, and Power) demands while delivering exceptional resilience and performance. Developed for Inmarsat’s U.S. government division, now Viasat, the RFFE is a high-performing, compact solution. Going from scratch to manufacturing in 12 months, TTP pushed component technologies to their limits in creating a high-performing RFFE design significantly smaller and more efficient than its predecessor, now used in multiple applications. Read the full case study here: https://lnkd.in/e7asxs89

How can we balance complexity, patient comfort, and device innovation in biotherapeutic delivery? As advanced therapies shift from hospitals to homes, delivering large-volume, highly viscous biotherapeutics presents significant challenges. In this insight piece by TTP’s Head of Drug Delivery and Digital Health, Steve Gowers, we follow a device team lead navigating a multi-layered decision-making process, balancing patient comfort, formulation needs, and device capabilities. Michelle's journey highlights the trade-offs required to create effective solutions, from managing infusion speed and needle size to addressing usability and adherence. Read the full insight: https://lnkd.in/ezViZhYF #AdvancedTherapies #DrugDelivery #viscousity #biotherapeutics #patientcare

Empowering frontline workers with real-time AI support, Augmented and TTP are transforming workplace safety through next-gen smart glasses. Designed to provide seamless, hands-free access to critical data and virtual assistance, these innovative glasses enable workers across diverse industries to operate more safely and efficiently, no matter where the job takes them. Read the full case study here: https://lnkd.in/eUkAx5_Z

Last week, our diagnostics team were featured in the #AMR and Infectious Diseases Campaign in the Guardian. TTP's Elena Boland, Giles Sanders, Keiko Yata and Kate Rouse discussed how accurate UTI diagnosis slows AMR, why current methods of diagnosis are unreliable and diagnostics that can address women's health and AMR. You can read the full interview here: https://lnkd.in/dyp9875b #womenshealth #pointofcarediagnostics #diagnostics #LifeSciences

We're teaming up with Cambridge Network to host: 'Women in STEM: Strategies for an Impactful Career' 📅 3rd December 🕒 6 PM – 9 PM 📍 Post Doc Centre, Eddington, Cambridge The event will offer practical advice and inspiration through a variety of activities, including a panel discussion with TTP Consultants on "The Future of Women in STEM". Get your free ticket today: https://lnkd.in/d_Xgzddj We hope to see you there! #womeninSTEM #womeninTEC #STEMcareers

From cancer chemotherapy to C-sections, much of the healthcare we take for granted today will become high-risk if serious infections can no longer be treated with antibiotics. Already, each year over 1 million deaths globally are directly attributable to antimicrobial resistance (AMR). That's why World #AMR Awareness Week is such an important campaign for the diagnostics industry. Hear from our Diagnostic's team on the reasons AMR week is important to them. You can also read our latest insight piece here: https://lnkd.in/eim5BSMc #WAAW #AMR #WomensHealth Elena Boland Giles Sanders Keiko Yata Kate Rouse

Suspension formulations offer exciting potential but come with challenges like maintaining homogeneity and balancing device complexity with usability. In this Q&A, TTP’s Matt Parker, Alastair Gregory, and Benjamin Hatton discuss how tailored release rates, advanced modelling, and close collaboration between formulation and device teams are unlocking new possibilities for patient-friendly, long-acting therapies. Read the full insight: https://lnkd.in/ez5fP6tD #AdvancedTherapies #DrugDelivery

What do we need to improve UTI diagnostics? During World #AMR Awareness Week, Keiko Yata and Kate R. discuss how more accurate and rapid diagnostics could improve patient care for UTI as well as the growing problem of antimicrobial resistance (AMR) and what that could look like. In our latest insights piece, 'UTI Diagnostics: An opportunity to improve antimicrobial stewardship and women’s health' where Elena Boland discusses what can we do to improve the situation right now this and how point-of-care testing could revolutionise UTI diagnosis and treatment, plus more. Read the full insight piece here: https://lnkd.in/eqbBB24t #WAAW #AMR #WomensHealth

Maritime expeditionary users need reliable, high-speed connectivity globally, especially in challenging environments. Viasat partnered with TTP and SpaceCom to design and develop a compact new terminal with integrated antenna. It had to deliver 3 Mbps over the global L-band ELERA network under adverse conditions and function standalone or alongside Viasat Global Xpress (GX) terminals. Read the full case study here: https://lnkd.in/em2fz-3K

UTI’s have a major impact on the health of millions and approaches to rapidly detect and provide effective treatment would have a major impact on healthcare and ultimately help reduce the emergence of further antibiotic-resistant strains. TTP and ODx Innovation developed a phenotyping platform that detects urinary tract infections and identifies the sensitivity of the infection to a range of antibiotics. Detection of bacterial infections at a concentration of 105 cfu within 10-20 minutes has been demonstrated with calling of antibiotic susceptibility to 6 common antibiotics in less than 60 minutes. Read the full case study here: https://lnkd.in/eq8MCCTN #WAAW #AMR #WomensHealth